FNBT
PPH icon

FineMark National Bank & Trust’s VanEck Pharmaceutical ETF PPH Stock Holding History

FineMark National Bank & Trust’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-54
Closed -$3K – 1440
2014
Q1 		$3K Hold
54
– – ﹤0.01% 1243
2013
Q4 		$3K Buy
+54
New +$2.73K ﹤0.01% 1247

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
NCM
Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MIM
Macroview Investment Management Bethesda, Maryland $144M AUM 19.29% 1-Year Est. Return
CC
Columbia Capital Fullerton, California $91.6M AUM 27.93% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
MA
Montag & Associates Atlanta, Georgia $2.15B AUM 20.86% 1-Year Est. Return

FineMark National Bank & Trust's PPH Position: Q2 2014 in Review

FineMark National Bank & Trust sold out of VanEck Pharmaceutical ETF (PPH) in Q2 2014, closing a stake of 54 shares — an estimated $3K sold.

FineMark National Bank & Trust first reported a position in PPH in Q4 2013 and held it in 2 quarters. The position peaked at $3K in Q1 2014. 54 funds tracked by Wall St. Rank hold PPH as of Q2 2014.

  • FineMark National Bank & Trust reported no remaining VanEck Pharmaceutical ETF position as of Q2 2014 after selling out during the quarter.
  • FineMark National Bank & Trust sold 54 VanEck Pharmaceutical ETF shares in Q2 2014, an estimated $3K.
  • FineMark National Bank & Trust first reported a position in VanEck Pharmaceutical ETF in Q4 2013 and held it in 2 quarters.
  • FineMark National Bank & Trust's VanEck Pharmaceutical ETF position peaked at $3K in Q1 2014.
  • 54 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q2 2014.

Based on FineMark National Bank & Trust's 13F filing for Q2 2014, filed 13 Aug 2014.